Hepatoma Research
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.8 | Q3 | 27.5% | 0.455 | Q3 | 57.6% |
| 2024 | 1.2 | Q4 | 19.7% | 0.367 | Q3 | 52.1% |
| 2023 | 1.7 | Q4 | 23.0% | 0.417 | Q3 | 59.0% |
| 2022 | — | — | 0.385 | Q3 | 58.1% | |
| 2021 | — | — | — | 5.8% | ||
| 2020 | — | — | — | 0.0% | ||
| 2019 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2394-5079
ISSN
2454-2520
region
Northern America
coverage
2019-2025